ArticleHealth psychology research2022

Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Hannah W Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.